I agree, uplisting is a hurdle CTIX must get over before the sp relflect the pipeline improvement.
Validated results showing efficacy will trump everything when it comes.
As far as uplisting goes, I think much is going on that we don't see. Leo has proven to be an excellent manager of the many tasks that have been necessary to get us where we are. And he has orchestrated them in an unbelievably positive manner as regards the various K trials.
When he has everything in place he will present it to the public and I think it will be an impressive event, true Leo style.
It was just a couple weeks ago they announced the acquisition of the new compounds and he is already addressing publicly getting the trial approved and scheduled. I'm amazed that he was able to get the purchase done so quickly and cleanly.
I couldn't be happier with what Leo has done in the past 15 months since I became aware of CTIX.
Wish all my investments were managed as well as this.